Rivastigmine 9.5 mg/24h (Rivastigmine PATCH, EXTENDED RELEASE) 9.5 mg/24h

Rivastigmine 9.5 mg/24h patches offer extended-release transdermal delivery for cognitive support. Learn about uses, effects, and precautions.

Strength

9.5 mg/24h

Pack Size

30 PATCH in 1 CARTON (0781-7309-31) / 24 h in 1 PATCH (0781-7309-58)

Manufacturer / TM Owner

Sandoz Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rivastigmine patches are commonly used to support cognitive function in conditions affecting memory and thinking. This transdermal form provides a steady release of the medication over 24 hours, which may help maintain consistent levels in the body. Rivastigmine is often considered for its potential benefits in managing symptoms related to cognitive decline.

Side Effects

Common effects of Rivastigmine patches may include skin irritation at the application site, nausea, and dizziness. Some users may experience changes in appetite or sleep patterns. These effects can vary and are not experienced by everyone.

Precautions & Warnings

Handle Rivastigmine patches carefully to avoid skin irritation. Apply the patch to clean, dry skin and avoid exposing it to heat or water. Store the patches at room temperature and keep them out of reach of children. Always follow the instructions provided by your healthcare professional.

Avoid Interactions

Rivastigmine may interact with other medications, including those that affect the nervous system or the digestive system. It is important to inform your healthcare provider about all medications you are taking. Avoid consuming alcohol while using Rivastigmine patches, as it may increase the risk of side effects.

Frequently Asked Questions

Rivastigmine is used to support cognitive function and manage symptoms related to cognitive decline.

Rivastigmine patches provide a steady release of the medication through the skin, maintaining consistent levels in the body over 24 hours.

Common side effects may include skin irritation, nausea, dizziness, and changes in appetite or sleep patterns.

Apply the patch to clean, dry skin and avoid exposing it to heat or water. Follow the instructions provided by your healthcare professional.

It is generally advised to avoid alcohol while using Rivastigmine patches, as it may increase the risk of side effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.